IKT
Price
$2.23
Change
-$0.03 (-1.33%)
Updated
May 1, 04:59 PM (EDT)
Capitalization
167.27M
SPRB
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Apr 30 closing price
Capitalization
3.32M
6 days until earnings call
Ad is loading...

IKT vs SPRB

Header iconIKT vs SPRB Comparison
Open Charts IKT vs SPRBBanner chart's image
Inhibikase Therapeutics
Price$2.23
Change-$0.03 (-1.33%)
Volume$400
Capitalization167.27M
Spruce Biosciences
Price$0.08
Change-$0.00 (-0.00%)
Volume$2.86M
Capitalization3.32M
IKT vs SPRB Comparison Chart
Loading...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IKT vs. SPRB commentary
May 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKT is a StrongBuy and SPRB is a Hold.

Ad is loading...
COMPARISON
Comparison
May 01, 2025
Stock price -- (IKT: $2.27 vs. SPRB: $0.08)
Brand notoriety: IKT and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKT: 93% vs. SPRB: 164%
Market capitalization -- IKT: $167.27M vs. SPRB: $3.32M
IKT [@Biotechnology] is valued at $167.27M. SPRB’s [@Biotechnology] market capitalization is $3.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKT’s FA Score shows that 1 FA rating(s) are green whileSPRB’s FA Score has 1 green FA rating(s).

  • IKT’s FA Score: 1 green, 4 red.
  • SPRB’s FA Score: 1 green, 4 red.
According to our system of comparison, IKT is a better buy in the long-term than SPRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKT’s TA Score shows that 5 TA indicator(s) are bullish while SPRB’s TA Score has 4 bullish TA indicator(s).

  • IKT’s TA Score: 5 bullish, 3 bearish.
  • SPRB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IKT is a better buy in the short-term than SPRB.

Price Growth

IKT (@Biotechnology) experienced а +4.86% price change this week, while SPRB (@Biotechnology) price change was -40.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.06%. For the same industry, the average monthly price growth was +8.47%, and the average quarterly price growth was -6.97%.

Reported Earning Dates

IKT is expected to report earnings on Mar 27, 2025.

SPRB is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IKT($167M) has a higher market cap than SPRB($3.32M). IKT YTD gains are higher at: -30.308 vs. SPRB (-81.167). IKT has higher annual earnings (EBITDA): -20.04M vs. SPRB (-39.02M). SPRB has more cash in the bank: 60.1M vs. IKT (3.24M). IKT has less debt than SPRB: IKT (145K) vs SPRB (3.23M). SPRB has higher revenues than IKT: SPRB (7.1M) vs IKT (0).
IKTSPRBIKT / SPRB
Capitalization167M3.32M5,035%
EBITDA-20.04M-39.02M51%
Gain YTD-30.308-81.16737%
P/E RatioN/AN/A-
Revenue07.1M-
Total Cash3.24M60.1M5%
Total Debt145K3.23M4%
TECHNICAL ANALYSIS
Technical Analysis
IKTSPRB
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THOCX36.690.04
+0.11%
Thornburg Global Opportunities C
UEPSX17.79N/A
N/A
ProFunds Europe 30 Svc
LIDAX8.95N/A
N/A
Lord Abbett International Value A
WMKSX14.33N/A
N/A
WesMark Small Company Fund
SVFCX67.97N/A
N/A
Smead Value C

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with CRGX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then CRGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+0.67%
CRGX - IKT
39%
Loosely correlated
+0.44%
VERV - IKT
33%
Poorly correlated
+3.39%
ARWR - IKT
32%
Poorly correlated
+2.97%
IDYA - IKT
29%
Poorly correlated
+2.18%
RNTX - IKT
28%
Poorly correlated
-4.49%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with MTVA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
-4.58%
MTVA - SPRB
61%
Loosely correlated
-2.45%
IMRX - SPRB
52%
Loosely correlated
-20.41%
MLEC - SPRB
51%
Loosely correlated
+2.74%
GNFT - SPRB
39%
Loosely correlated
+1.11%
IMCR - SPRB
37%
Loosely correlated
-1.21%
More